GO:0005575 | cellular_component | 87.95% (73/83) | 0.53 | 0.0 | 3.7e-05 |
GO:0005874 | microtubule | 12.05% (10/83) | 3.41 | 0.0 | 3.8e-05 |
GO:0110165 | cellular anatomical entity | 87.95% (73/83) | 0.55 | 0.0 | 4.9e-05 |
GO:0099513 | polymeric cytoskeletal fiber | 12.05% (10/83) | 3.16 | 0.0 | 9.8e-05 |
GO:0099081 | supramolecular polymer | 12.05% (10/83) | 3.08 | 0.0 | 0.000105 |
GO:0099512 | supramolecular fiber | 12.05% (10/83) | 3.08 | 0.0 | 0.000105 |
GO:0016020 | membrane | 54.22% (45/83) | 0.94 | 1e-06 | 0.000145 |
GO:0000139 | Golgi membrane | 12.05% (10/83) | 3.0 | 0.0 | 0.00015 |
GO:0006544 | glycine metabolic process | 4.82% (4/83) | 5.88 | 1e-06 | 0.000151 |
GO:0031410 | cytoplasmic vesicle | 20.48% (17/83) | 1.97 | 1e-06 | 0.000213 |
GO:0031984 | organelle subcompartment | 15.66% (13/83) | 2.35 | 1e-06 | 0.000228 |
GO:0097708 | intracellular vesicle | 20.48% (17/83) | 1.93 | 2e-06 | 0.000229 |
GO:0098791 | Golgi apparatus subcompartment | 13.25% (11/83) | 2.64 | 2e-06 | 0.000231 |
GO:0099080 | supramolecular complex | 14.46% (12/83) | 2.46 | 2e-06 | 0.000232 |
GO:0043229 | intracellular organelle | 66.27% (55/83) | 0.73 | 1e-06 | 0.000233 |
GO:0005829 | cytosol | 34.94% (29/83) | 1.29 | 2e-06 | 0.000237 |
GO:0043226 | organelle | 66.27% (55/83) | 0.72 | 1e-06 | 0.00024 |
GO:0004001 | adenosine kinase activity | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0006169 | adenosine salvage | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0006175 | dATP biosynthetic process | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0044342 | type B pancreatic cell proliferation | 2.41% (2/83) | 8.88 | 4e-06 | 0.000373 |
GO:0098588 | bounding membrane of organelle | 24.1% (20/83) | 1.62 | 5e-06 | 0.000375 |
GO:0031982 | vesicle | 20.48% (17/83) | 1.8 | 6e-06 | 0.000449 |
GO:0051223 | regulation of protein transport | 8.43% (7/83) | 3.43 | 4e-06 | 0.000453 |
GO:0003674 | molecular_function | 83.13% (69/83) | 0.48 | 4e-06 | 0.000458 |
GO:0030133 | transport vesicle | 7.23% (6/83) | 3.71 | 7e-06 | 0.000526 |
GO:0005876 | spindle microtubule | 6.02% (5/83) | 4.19 | 9e-06 | 0.000618 |
GO:0070201 | regulation of establishment of protein localization | 8.43% (7/83) | 3.25 | 9e-06 | 0.000653 |
GO:0019900 | kinase binding | 12.05% (10/83) | 2.5 | 1.1e-05 | 0.000725 |
GO:0016741 | transferase activity, transferring one-carbon groups | 9.64% (8/83) | 2.9 | 1.2e-05 | 0.000812 |
GO:0043231 | intracellular membrane-bounded organelle | 57.83% (48/83) | 0.73 | 1.7e-05 | 0.001048 |
GO:0005886 | plasma membrane | 31.33% (26/83) | 1.2 | 2.7e-05 | 0.001383 |
GO:0048104 | establishment of body hair or bristle planar orientation | 2.41% (2/83) | 7.88 | 2.7e-05 | 0.001397 |
GO:0009153 | purine deoxyribonucleotide biosynthetic process | 2.41% (2/83) | 7.88 | 2.7e-05 | 0.001397 |
GO:0044209 | AMP salvage | 2.41% (2/83) | 7.88 | 2.7e-05 | 0.001397 |
GO:0046060 | dATP metabolic process | 2.41% (2/83) | 7.88 | 2.7e-05 | 0.001397 |
GO:0046086 | adenosine biosynthetic process | 2.41% (2/83) | 7.88 | 2.7e-05 | 0.001397 |
GO:0043227 | membrane-bounded organelle | 57.83% (48/83) | 0.71 | 2.3e-05 | 0.001419 |
GO:0000226 | microtubule cytoskeleton organization | 9.64% (8/83) | 2.72 | 3e-05 | 0.001419 |
GO:0005515 | protein binding | 60.24% (50/83) | 0.67 | 3e-05 | 0.001442 |
GO:0046653 | tetrahydrofolate metabolic process | 3.61% (3/83) | 5.66 | 2.9e-05 | 0.001452 |
GO:1901605 | alpha-amino acid metabolic process | 9.64% (8/83) | 2.75 | 2.6e-05 | 0.001555 |
GO:0008017 | microtubule binding | 7.23% (6/83) | 3.3 | 3.4e-05 | 0.001562 |
GO:0019901 | protein kinase binding | 9.64% (8/83) | 2.7 | 3.4e-05 | 0.001569 |
GO:0032991 | protein-containing complex | 28.92% (24/83) | 1.23 | 4.5e-05 | 0.001957 |
GO:0001737 | establishment of imaginal disc-derived wing hair orientation | 2.41% (2/83) | 7.56 | 4.4e-05 | 0.001978 |
GO:0009071 | serine family amino acid catabolic process | 3.61% (3/83) | 5.42 | 4.8e-05 | 0.002058 |
GO:0008150 | biological_process | 81.93% (68/83) | 0.41 | 4.9e-05 | 0.002062 |
GO:0009987 | cellular process | 73.49% (61/83) | 0.49 | 5.9e-05 | 0.00236 |
GO:0006730 | one-carbon metabolic process | 3.61% (3/83) | 5.34 | 5.8e-05 | 0.002364 |
GO:0000922 | spindle pole | 4.82% (4/83) | 4.24 | 6.3e-05 | 0.002509 |
GO:0006166 | purine ribonucleoside salvage | 2.41% (2/83) | 7.29 | 6.6e-05 | 0.002579 |
GO:0009066 | aspartate family amino acid metabolic process | 4.82% (4/83) | 4.15 | 8e-05 | 0.003034 |
GO:0031090 | organelle membrane | 28.92% (24/83) | 1.17 | 8.2e-05 | 0.00308 |
GO:0000096 | sulfur amino acid metabolic process | 4.82% (4/83) | 4.12 | 8.6e-05 | 0.003148 |
GO:0005875 | microtubule associated complex | 4.82% (4/83) | 4.08 | 9.5e-05 | 0.003272 |
GO:0009069 | serine family amino acid metabolic process | 4.82% (4/83) | 4.08 | 9.5e-05 | 0.003272 |
GO:0006167 | AMP biosynthetic process | 2.41% (2/83) | 7.07 | 9.3e-05 | 0.0033 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2.41% (2/83) | 7.07 | 9.3e-05 | 0.0033 |
GO:0016462 | pyrophosphatase activity | 8.43% (7/83) | 2.71 | 0.000101 | 0.003373 |
GO:0006760 | folic acid-containing compound metabolic process | 3.61% (3/83) | 5.07 | 0.0001 | 0.003375 |
GO:0007051 | spindle organization | 6.02% (5/83) | 3.43 | 0.000105 | 0.003441 |
GO:0042558 | pteridine-containing compound metabolic process | 3.61% (3/83) | 5.04 | 0.000107 | 0.003455 |
GO:0005802 | trans-Golgi network | 9.64% (8/83) | 2.43 | 0.000124 | 0.003474 |
GO:0004372 | glycine hydroxymethyltransferase activity | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0019264 | glycine biosynthetic process from serine | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0070905 | serine binding | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0032261 | purine nucleotide salvage | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0106380 | purine ribonucleotide salvage | 2.41% (2/83) | 6.88 | 0.000124 | 0.003504 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.43% (7/83) | 2.69 | 0.00011 | 0.003506 |
GO:0030140 | trans-Golgi network transport vesicle | 3.61% (3/83) | 5.0 | 0.000115 | 0.003539 |
GO:0015631 | tubulin binding | 7.23% (6/83) | 2.99 | 0.000115 | 0.003582 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 8.43% (7/83) | 2.64 | 0.000138 | 0.003813 |
GO:0044283 | small molecule biosynthetic process | 14.46% (12/83) | 1.82 | 0.000142 | 0.003866 |
GO:0034432 | bis(5'-adenosyl)-pentaphosphatase activity | 2.41% (2/83) | 6.71 | 0.000159 | 0.004011 |
GO:0043849 | Ras palmitoyltransferase activity | 2.41% (2/83) | 6.71 | 0.000159 | 0.004011 |
GO:0042451 | purine nucleoside biosynthetic process | 2.41% (2/83) | 6.71 | 0.000159 | 0.004011 |
GO:0046129 | purine ribonucleoside biosynthetic process | 2.41% (2/83) | 6.71 | 0.000159 | 0.004011 |
GO:0008092 | cytoskeletal protein binding | 9.64% (8/83) | 2.38 | 0.000152 | 0.004086 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 3.61% (3/83) | 4.85 | 0.000159 | 0.004205 |
GO:0043094 | cellular metabolic compound salvage | 4.82% (4/83) | 3.86 | 0.000175 | 0.00437 |
GO:0052546 | cell wall pectin metabolic process | 4.82% (4/83) | 3.84 | 0.000186 | 0.004526 |
GO:0032259 | methylation | 8.43% (7/83) | 2.57 | 0.000185 | 0.004569 |
GO:0043101 | purine-containing compound salvage | 2.41% (2/83) | 6.56 | 0.000198 | 0.004669 |
GO:0043174 | nucleoside salvage | 2.41% (2/83) | 6.56 | 0.000198 | 0.004669 |
GO:0005488 | binding | 69.88% (58/83) | 0.48 | 0.000195 | 0.004696 |
GO:0022607 | cellular component assembly | 18.07% (15/83) | 1.51 | 0.000207 | 0.004823 |
GO:0030120 | vesicle coat | 3.61% (3/83) | 4.71 | 0.000212 | 0.004877 |
GO:0006520 | cellular amino acid metabolic process | 9.64% (8/83) | 2.29 | 0.000233 | 0.005307 |
GO:0051256 | mitotic spindle midzone assembly | 2.41% (2/83) | 6.42 | 0.000242 | 0.005396 |
GO:0046085 | adenosine metabolic process | 2.41% (2/83) | 6.42 | 0.000242 | 0.005396 |
GO:0000910 | cytokinesis | 6.02% (5/83) | 3.16 | 0.000251 | 0.005544 |
GO:0032880 | regulation of protein localization | 8.43% (7/83) | 2.49 | 0.000258 | 0.005623 |
GO:0006555 | methionine metabolic process | 3.61% (3/83) | 4.61 | 0.000262 | 0.005658 |
GO:0007017 | microtubule-based process | 9.64% (8/83) | 2.26 | 0.000265 | 0.005672 |
GO:0006563 | L-serine metabolic process | 3.61% (3/83) | 4.58 | 0.000275 | 0.005773 |
GO:1901566 | organonitrogen compound biosynthetic process | 16.87% (14/83) | 1.54 | 0.000274 | 0.005804 |
GO:0050673 | epithelial cell proliferation | 2.41% (2/83) | 6.29 | 0.00029 | 0.005959 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 3.61% (3/83) | 4.56 | 0.000289 | 0.006007 |
GO:0003924 | GTPase activity | 6.02% (5/83) | 3.11 | 0.000298 | 0.00607 |
GO:0051225 | spindle assembly | 4.82% (4/83) | 3.64 | 0.00031 | 0.006253 |
GO:0022402 | cell cycle process | 13.25% (11/83) | 1.79 | 0.000321 | 0.006341 |
GO:0052325 | cell wall pectin biosynthetic process | 3.61% (3/83) | 4.51 | 0.000319 | 0.006367 |
GO:0016192 | vesicle-mediated transport | 10.84% (9/83) | 2.05 | 0.000333 | 0.006517 |
GO:0042455 | ribonucleoside biosynthetic process | 2.41% (2/83) | 6.18 | 0.000342 | 0.006642 |
GO:0030135 | coated vesicle | 4.82% (4/83) | 3.56 | 0.000386 | 0.007429 |
GO:0006545 | glycine biosynthetic process | 2.41% (2/83) | 6.07 | 0.000399 | 0.007529 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 2.41% (2/83) | 6.07 | 0.000399 | 0.007529 |
GO:0007010 | cytoskeleton organization | 9.64% (8/83) | 2.16 | 0.000423 | 0.007915 |
GO:0035999 | tetrahydrofolate interconversion | 2.41% (2/83) | 5.97 | 0.000459 | 0.008301 |
GO:0051255 | spindle midzone assembly | 2.41% (2/83) | 5.97 | 0.000459 | 0.008301 |
GO:0019206 | nucleoside kinase activity | 2.41% (2/83) | 5.97 | 0.000459 | 0.008301 |
GO:0031224 | intrinsic component of membrane | 21.69% (18/83) | 1.24 | 0.000453 | 0.008411 |
GO:0043168 | anion binding | 20.48% (17/83) | 1.28 | 0.000508 | 0.009098 |
GO:0005525 | GTP binding | 6.02% (5/83) | 2.93 | 0.000524 | 0.009159 |
GO:0002178 | palmitoyltransferase complex | 2.41% (2/83) | 5.88 | 0.000524 | 0.009235 |
GO:0046655 | folic acid metabolic process | 2.41% (2/83) | 5.88 | 0.000524 | 0.009235 |
GO:0046907 | intracellular transport | 12.05% (10/83) | 1.8 | 0.000594 | 0.009873 |
GO:0045489 | pectin biosynthetic process | 4.82% (4/83) | 3.39 | 0.000602 | 0.009933 |
GO:0010070 | zygote asymmetric cell division | 2.41% (2/83) | 5.79 | 0.000593 | 0.00995 |
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 2.41% (2/83) | 5.79 | 0.000593 | 0.00995 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 2.41% (2/83) | 5.79 | 0.000593 | 0.00995 |
GO:0046033 | AMP metabolic process | 2.41% (2/83) | 5.79 | 0.000593 | 0.00995 |
GO:0008168 | methyltransferase activity | 7.23% (6/83) | 2.54 | 0.000609 | 0.009975 |
GO:0071840 | cellular component organization or biogenesis | 32.53% (27/83) | 0.9 | 0.000589 | 0.010198 |
GO:0046394 | carboxylic acid biosynthetic process | 10.84% (9/83) | 1.9 | 0.00067 | 0.010248 |
GO:0045179 | apical cortex | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0030126 | COPI vesicle coat | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0048599 | oocyte development | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0045298 | tubulin complex | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0009163 | nucleoside biosynthetic process | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 2.41% (2/83) | 5.71 | 0.000667 | 0.010275 |
GO:0060341 | regulation of cellular localization | 8.43% (7/83) | 2.25 | 0.00068 | 0.010329 |
GO:0015031 | protein transport | 10.84% (9/83) | 1.9 | 0.000695 | 0.010486 |
GO:1901606 | alpha-amino acid catabolic process | 4.82% (4/83) | 3.36 | 0.000653 | 0.010535 |
GO:0030117 | membrane coat | 3.61% (3/83) | 4.16 | 0.00065 | 0.010558 |
GO:0070592 | cell wall polysaccharide biosynthetic process | 4.82% (4/83) | 3.32 | 0.000722 | 0.010813 |
GO:0042102 | positive regulation of T cell proliferation | 2.41% (2/83) | 5.63 | 0.000744 | 0.011061 |
GO:0009070 | serine family amino acid biosynthetic process | 3.61% (3/83) | 4.09 | 0.00075 | 0.011077 |
GO:0071705 | nitrogen compound transport | 14.46% (12/83) | 1.55 | 0.000779 | 0.011342 |
GO:0032561 | guanyl ribonucleotide binding | 6.02% (5/83) | 2.8 | 0.000785 | 0.011348 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.61% (3/83) | 4.07 | 0.000777 | 0.011389 |
GO:0001736 | establishment of planar polarity | 2.41% (2/83) | 5.56 | 0.000826 | 0.011692 |
GO:0006565 | L-serine catabolic process | 2.41% (2/83) | 5.56 | 0.000826 | 0.011692 |
GO:0019001 | guanyl nucleotide binding | 6.02% (5/83) | 2.79 | 0.000817 | 0.011724 |
GO:1901607 | alpha-amino acid biosynthetic process | 6.02% (5/83) | 2.77 | 0.00086 | 0.012102 |
GO:0140694 | non-membrane-bounded organelle assembly | 6.02% (5/83) | 2.76 | 0.000883 | 0.012335 |
GO:0009063 | cellular amino acid catabolic process | 4.82% (4/83) | 3.24 | 0.000891 | 0.012373 |
GO:0044038 | cell wall macromolecule biosynthetic process | 4.82% (4/83) | 3.23 | 0.000908 | 0.012439 |
GO:0070589 | cellular component macromolecule biosynthetic process | 4.82% (4/83) | 3.23 | 0.000908 | 0.012439 |
GO:0005798 | Golgi-associated vesicle | 3.61% (3/83) | 3.99 | 0.000919 | 0.012509 |
GO:0016597 | amino acid binding | 3.61% (3/83) | 3.94 | 0.001012 | 0.013253 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 2.41% (2/83) | 5.42 | 0.001001 | 0.013279 |
GO:0042129 | regulation of T cell proliferation | 2.41% (2/83) | 5.42 | 0.001001 | 0.013279 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 2.41% (2/83) | 5.42 | 0.001001 | 0.013279 |
GO:0005794 | Golgi apparatus | 12.05% (10/83) | 1.7 | 0.001011 | 0.013328 |
GO:0070925 | organelle assembly | 7.23% (6/83) | 2.4 | 0.000991 | 0.013397 |
GO:0009292 | horizontal gene transfer | 3.61% (3/83) | 3.93 | 0.001044 | 0.013505 |
GO:0009294 | DNA-mediated transformation | 3.61% (3/83) | 3.93 | 0.001044 | 0.013505 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.66% (13/83) | 1.41 | 0.001082 | 0.013833 |
GO:0045184 | establishment of protein localization | 10.84% (9/83) | 1.81 | 0.001082 | 0.013918 |
GO:0051641 | cellular localization | 15.66% (13/83) | 1.41 | 0.001126 | 0.014303 |
GO:0046500 | S-adenosylmethionine metabolic process | 2.41% (2/83) | 5.29 | 0.001193 | 0.014705 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 2.41% (2/83) | 5.29 | 0.001193 | 0.014705 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 2.41% (2/83) | 5.29 | 0.001193 | 0.014705 |
GO:0050671 | positive regulation of lymphocyte proliferation | 2.41% (2/83) | 5.29 | 0.001193 | 0.014705 |
GO:0048193 | Golgi vesicle transport | 6.02% (5/83) | 2.67 | 0.001174 | 0.014819 |
GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:1903540 | establishment of protein localization to postsynaptic membrane | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0014742 | positive regulation of muscle hypertrophy | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0043173 | nucleotide salvage | 2.41% (2/83) | 5.24 | 0.001295 | 0.014992 |
GO:0071702 | organic substance transport | 15.66% (13/83) | 1.39 | 0.001236 | 0.015156 |
GO:0017022 | myosin binding | 3.61% (3/83) | 3.84 | 0.00125 | 0.015234 |
GO:0008266 | poly(U) RNA binding | 3.61% (3/83) | 3.81 | 0.001324 | 0.01525 |
GO:0016043 | cellular component organization | 30.12% (25/83) | 0.88 | 0.00126 | 0.015262 |
GO:0016053 | organic acid biosynthetic process | 10.84% (9/83) | 1.76 | 0.00134 | 0.015352 |
GO:0006612 | protein targeting to membrane | 3.61% (3/83) | 3.79 | 0.001362 | 0.015518 |
GO:0003824 | catalytic activity | 49.4% (41/83) | 0.58 | 0.00143 | 0.016198 |
GO:0010289 | homogalacturonan biosynthetic process | 2.41% (2/83) | 5.12 | 0.001511 | 0.016664 |
GO:0097431 | mitotic spindle pole | 2.41% (2/83) | 5.12 | 0.001511 | 0.016664 |
GO:0050670 | regulation of lymphocyte proliferation | 2.41% (2/83) | 5.12 | 0.001511 | 0.016664 |
GO:0070665 | positive regulation of leukocyte proliferation | 2.41% (2/83) | 5.12 | 0.001511 | 0.016664 |
GO:0008187 | poly-pyrimidine tract binding | 3.61% (3/83) | 3.75 | 0.001481 | 0.016684 |
GO:0000281 | mitotic cytokinesis | 3.61% (3/83) | 3.74 | 0.001521 | 0.016695 |
GO:0045488 | pectin metabolic process | 6.02% (5/83) | 2.58 | 0.001547 | 0.016891 |
GO:0098877 | neurotransmitter receptor transport to plasma membrane | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0099639 | neurotransmitter receptor transport, endosome to plasma membrane | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0032944 | regulation of mononuclear cell proliferation | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0005513 | detection of calcium ion | 2.41% (2/83) | 5.07 | 0.001625 | 0.017025 |
GO:0000271 | polysaccharide biosynthetic process | 6.02% (5/83) | 2.56 | 0.001635 | 0.01705 |
GO:0000911 | cytokinesis by cell plate formation | 3.61% (3/83) | 3.7 | 0.001648 | 0.0171 |
GO:0019842 | vitamin binding | 4.82% (4/83) | 3.01 | 0.001589 | 0.017165 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6.02% (5/83) | 2.57 | 0.001582 | 0.01718 |
GO:0010393 | galacturonan metabolic process | 6.02% (5/83) | 2.55 | 0.001671 | 0.017254 |
GO:0008652 | cellular amino acid biosynthetic process | 6.02% (5/83) | 2.55 | 0.001708 | 0.017547 |
GO:0072657 | protein localization to membrane | 6.02% (5/83) | 2.54 | 0.001745 | 0.017585 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 2.41% (2/83) | 5.02 | 0.001742 | 0.017643 |
GO:0099637 | neurotransmitter receptor transport | 2.41% (2/83) | 5.02 | 0.001742 | 0.017643 |
GO:1903539 | protein localization to postsynaptic membrane | 2.41% (2/83) | 5.02 | 0.001742 | 0.017643 |
GO:0036094 | small molecule binding | 22.89% (19/83) | 1.03 | 0.001803 | 0.017996 |
GO:0090150 | establishment of protein localization to membrane | 4.82% (4/83) | 2.96 | 0.001796 | 0.01801 |
GO:0007164 | establishment of tissue polarity | 2.41% (2/83) | 4.97 | 0.001864 | 0.018091 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 2.41% (2/83) | 4.97 | 0.001864 | 0.018091 |
GO:0046128 | purine ribonucleoside metabolic process | 2.41% (2/83) | 4.97 | 0.001864 | 0.018091 |
GO:0030496 | midbody | 3.61% (3/83) | 3.64 | 0.001827 | 0.018147 |
GO:1901576 | organic substance biosynthetic process | 27.71% (23/83) | 0.9 | 0.001838 | 0.018171 |
GO:0046983 | protein dimerization activity | 12.05% (10/83) | 1.58 | 0.001885 | 0.018205 |
GO:0006886 | intracellular protein transport | 8.43% (7/83) | 2.0 | 0.001897 | 0.018238 |
GO:0019899 | enzyme binding | 14.46% (12/83) | 1.4 | 0.001855 | 0.018255 |
GO:0005789 | endoplasmic reticulum membrane | 9.64% (8/83) | 1.82 | 0.001935 | 0.018265 |
GO:0072522 | purine-containing compound biosynthetic process | 4.82% (4/83) | 2.93 | 0.001934 | 0.018346 |
GO:0051649 | establishment of localization in cell | 12.05% (10/83) | 1.57 | 0.00192 | 0.018375 |
GO:0010394 | homogalacturonan metabolic process | 2.41% (2/83) | 4.93 | 0.00199 | 0.018376 |
GO:0031489 | myosin V binding | 2.41% (2/83) | 4.93 | 0.00199 | 0.018376 |
GO:0062237 | protein localization to postsynapse | 2.41% (2/83) | 4.93 | 0.00199 | 0.018376 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 2.41% (2/83) | 4.93 | 0.00199 | 0.018376 |
GO:0070663 | regulation of leukocyte proliferation | 2.41% (2/83) | 4.93 | 0.00199 | 0.018376 |
GO:0005975 | carbohydrate metabolic process | 12.05% (10/83) | 1.57 | 0.001929 | 0.018376 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.41% (2/83) | 4.88 | 0.00212 | 0.019489 |
GO:0032555 | purine ribonucleotide binding | 15.66% (13/83) | 1.3 | 0.002131 | 0.019506 |
GO:0017076 | purine nucleotide binding | 15.66% (13/83) | 1.29 | 0.002255 | 0.020548 |
GO:0032501 | multicellular organismal process | 31.33% (26/83) | 0.8 | 0.002286 | 0.020743 |
GO:0030136 | clathrin-coated vesicle | 3.61% (3/83) | 3.51 | 0.00238 | 0.021498 |
GO:0005768 | endosome | 10.84% (9/83) | 1.63 | 0.002449 | 0.022033 |
GO:0007052 | mitotic spindle organization | 3.61% (3/83) | 3.49 | 0.00249 | 0.022303 |
GO:0009119 | ribonucleoside metabolic process | 2.41% (2/83) | 4.75 | 0.002533 | 0.022589 |
GO:0030312 | external encapsulating structure | 13.25% (11/83) | 1.42 | 0.002603 | 0.023122 |
GO:1903829 | positive regulation of protein localization | 4.82% (4/83) | 2.81 | 0.002633 | 0.023282 |
GO:0005814 | centriole | 2.41% (2/83) | 4.71 | 0.002678 | 0.023387 |
GO:0016409 | palmitoyltransferase activity | 2.41% (2/83) | 4.71 | 0.002678 | 0.023387 |
GO:0018345 | protein palmitoylation | 2.41% (2/83) | 4.71 | 0.002678 | 0.023387 |
GO:0032553 | ribonucleotide binding | 15.66% (13/83) | 1.26 | 0.002707 | 0.023545 |
GO:0009504 | cell plate | 3.61% (3/83) | 3.44 | 0.00272 | 0.023559 |
GO:0008104 | protein localization | 12.05% (10/83) | 1.5 | 0.002791 | 0.024077 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 2.41% (2/83) | 4.67 | 0.002827 | 0.024186 |
GO:0014743 | regulation of muscle hypertrophy | 2.41% (2/83) | 4.67 | 0.002827 | 0.024186 |
GO:0035418 | protein localization to synapse | 2.41% (2/83) | 4.59 | 0.003137 | 0.026618 |
GO:0006144 | purine nucleobase metabolic process | 2.41% (2/83) | 4.59 | 0.003137 | 0.026618 |
GO:0005976 | polysaccharide metabolic process | 8.43% (7/83) | 1.86 | 0.00323 | 0.027301 |
GO:0048168 | regulation of neuronal synaptic plasticity | 2.41% (2/83) | 4.56 | 0.003297 | 0.027535 |
GO:0097120 | receptor localization to synapse | 2.41% (2/83) | 4.56 | 0.003297 | 0.027535 |
GO:0042278 | purine nucleoside metabolic process | 2.41% (2/83) | 4.56 | 0.003297 | 0.027535 |
GO:0099738 | cell cortex region | 2.41% (2/83) | 4.52 | 0.003462 | 0.028792 |
GO:1902414 | protein localization to cell junction | 2.41% (2/83) | 4.49 | 0.00363 | 0.029835 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.41% (2/83) | 4.49 | 0.00363 | 0.029835 |
GO:0009086 | methionine biosynthetic process | 2.41% (2/83) | 4.49 | 0.00363 | 0.029835 |
GO:0009058 | biosynthetic process | 27.71% (23/83) | 0.82 | 0.003686 | 0.030177 |
GO:0099638 | endosome to plasma membrane protein transport | 2.41% (2/83) | 4.45 | 0.003802 | 0.030529 |
GO:0018198 | peptidyl-cysteine modification | 2.41% (2/83) | 4.45 | 0.003802 | 0.030529 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 2.41% (2/83) | 4.45 | 0.003802 | 0.030529 |
GO:0019692 | deoxyribose phosphate metabolic process | 2.41% (2/83) | 4.45 | 0.003802 | 0.030529 |
GO:0043502 | regulation of muscle adaptation | 2.41% (2/83) | 4.45 | 0.003802 | 0.030529 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 2.41% (2/83) | 4.42 | 0.003977 | 0.031696 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.41% (2/83) | 4.42 | 0.003977 | 0.031696 |
GO:0030659 | cytoplasmic vesicle membrane | 7.23% (6/83) | 2.0 | 0.004012 | 0.031857 |
GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity | 2.41% (2/83) | 4.39 | 0.004156 | 0.032751 |
GO:0010883 | regulation of lipid storage | 2.41% (2/83) | 4.39 | 0.004156 | 0.032751 |
GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity | 1.2% (1/83) | 7.88 | 0.004242 | 0.033056 |
GO:0106312 | methylenetetrahydrofolate reductase NADH activity | 1.2% (1/83) | 7.88 | 0.004242 | 0.033056 |
GO:0106313 | methylenetetrahydrofolate reductase NADPH activity | 1.2% (1/83) | 7.88 | 0.004242 | 0.033056 |
GO:0033036 | macromolecule localization | 13.25% (11/83) | 1.32 | 0.004326 | 0.033332 |
GO:0005813 | centrosome | 4.82% (4/83) | 2.61 | 0.004313 | 0.033357 |
GO:0051668 | localization within membrane | 6.02% (5/83) | 2.24 | 0.004302 | 0.033398 |
GO:0097367 | carbohydrate derivative binding | 15.66% (13/83) | 1.18 | 0.004368 | 0.033532 |
GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:0016417 | S-acyltransferase activity | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:0009262 | deoxyribonucleotide metabolic process | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:0019205 | nucleobase-containing compound kinase activity | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:0050870 | positive regulation of T cell activation | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 2.41% (2/83) | 4.32 | 0.004526 | 0.03376 |
GO:0010584 | pollen exine formation | 3.61% (3/83) | 3.19 | 0.004456 | 0.034083 |
GO:0044249 | cellular biosynthetic process | 25.3% (21/83) | 0.85 | 0.004482 | 0.034158 |
GO:1903047 | mitotic cell cycle process | 7.23% (6/83) | 1.95 | 0.00462 | 0.034338 |
GO:0005795 | Golgi stack | 2.41% (2/83) | 4.29 | 0.004716 | 0.034686 |
GO:1901998 | toxin transport | 2.41% (2/83) | 4.29 | 0.004716 | 0.034686 |
GO:0006996 | organelle organization | 16.87% (14/83) | 1.11 | 0.004742 | 0.03475 |
GO:0009152 | purine ribonucleotide biosynthetic process | 3.61% (3/83) | 3.16 | 0.0047 | 0.034807 |
GO:0016740 | transferase activity | 26.51% (22/83) | 0.81 | 0.004895 | 0.035747 |
GO:0012506 | vesicle membrane | 7.23% (6/83) | 1.93 | 0.004996 | 0.036361 |
GO:0030170 | pyridoxal phosphate binding | 3.61% (3/83) | 3.12 | 0.005037 | 0.036535 |
GO:0070279 | vitamin B6 binding | 3.61% (3/83) | 3.12 | 0.005124 | 0.036782 |
GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 2.41% (2/83) | 4.24 | 0.005108 | 0.03679 |
GO:0022409 | positive regulation of cell-cell adhesion | 2.41% (2/83) | 4.24 | 0.005108 | 0.03679 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 3.61% (3/83) | 3.11 | 0.005212 | 0.037156 |
GO:0033692 | cellular polysaccharide biosynthetic process | 4.82% (4/83) | 2.53 | 0.005206 | 0.03724 |
GO:0005618 | cell wall | 12.05% (10/83) | 1.36 | 0.005356 | 0.038057 |
GO:0051222 | positive regulation of protein transport | 3.61% (3/83) | 3.09 | 0.00539 | 0.038164 |
GO:0055038 | recycling endosome membrane | 2.41% (2/83) | 4.18 | 0.005514 | 0.038782 |
GO:1903037 | regulation of leukocyte cell-cell adhesion | 2.41% (2/83) | 4.18 | 0.005514 | 0.038782 |
GO:0010383 | cell wall polysaccharide metabolic process | 4.82% (4/83) | 2.5 | 0.005548 | 0.038894 |
GO:0006164 | purine nucleotide biosynthetic process | 3.61% (3/83) | 3.07 | 0.005571 | 0.038923 |
GO:0033157 | regulation of intracellular protein transport | 3.61% (3/83) | 3.05 | 0.005756 | 0.039687 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 3.61% (3/83) | 3.05 | 0.005756 | 0.039687 |
GO:0005338 | nucleotide-sugar transmembrane transporter activity | 2.41% (2/83) | 4.15 | 0.005722 | 0.039846 |
GO:0098796 | membrane protein complex | 7.23% (6/83) | 1.89 | 0.005744 | 0.039865 |
GO:0070727 | cellular macromolecule localization | 12.05% (10/83) | 1.34 | 0.005923 | 0.040704 |
GO:1903078 | positive regulation of protein localization to plasma membrane | 2.41% (2/83) | 4.07 | 0.006369 | 0.041073 |
GO:0005871 | kinesin complex | 2.41% (2/83) | 4.07 | 0.006369 | 0.041073 |
GO:0010306 | rhamnogalacturonan II biosynthetic process | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0010396 | rhamnogalacturonan II metabolic process | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0000073 | initial mitotic spindle pole body separation | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0110100 | spindle pole body separation | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0019530 | taurine metabolic process | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0003871 | 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0008705 | methionine synthase activity | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0042084 | 5-methyltetrahydrofolate-dependent methyltransferase activity | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0042085 | 5-methyltetrahydropteroyltri-L-glutamate-dependent methyltransferase activity | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0035175 | histone kinase activity (H3-S10 specific) | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0043203 | axon hillock | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0044022 | histone kinase activity (H3-S28 specific) | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:1905115 | regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:1905116 | positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1.2% (1/83) | 7.29 | 0.006357 | 0.041251 |
GO:0016021 | integral component of membrane | 16.87% (14/83) | 1.07 | 0.006061 | 0.041515 |
GO:0043177 | organic acid binding | 3.61% (3/83) | 3.02 | 0.006137 | 0.041902 |
GO:1904951 | positive regulation of establishment of protein localization | 3.61% (3/83) | 2.99 | 0.006533 | 0.042006 |
GO:1904377 | positive regulation of protein localization to cell periphery | 2.41% (2/83) | 4.05 | 0.006591 | 0.042119 |
GO:0050863 | regulation of T cell activation | 2.41% (2/83) | 4.05 | 0.006591 | 0.042119 |
GO:0044281 | small molecule metabolic process | 19.28% (16/83) | 0.98 | 0.00623 | 0.042395 |
GO:0032879 | regulation of localization | 12.05% (10/83) | 1.33 | 0.006303 | 0.042757 |
GO:0009561 | megagametogenesis | 2.41% (2/83) | 4.02 | 0.006817 | 0.043169 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 2.41% (2/83) | 4.02 | 0.006817 | 0.043169 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.41% (2/83) | 4.02 | 0.006817 | 0.043169 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 3.61% (3/83) | 2.95 | 0.007049 | 0.044237 |
GO:0015780 | nucleotide-sugar transmembrane transport | 2.41% (2/83) | 4.0 | 0.007047 | 0.044354 |
GO:0009853 | photorespiration | 2.41% (2/83) | 4.0 | 0.007047 | 0.044354 |
GO:0009260 | ribonucleotide biosynthetic process | 3.61% (3/83) | 2.91 | 0.007589 | 0.047481 |
GO:0005774 | vacuolar membrane | 12.05% (10/83) | 1.29 | 0.007747 | 0.048325 |
GO:0031122 | cytoplasmic microtubule organization | 3.61% (3/83) | 2.89 | 0.007811 | 0.048583 |
GO:0046395 | carboxylic acid catabolic process | 4.82% (4/83) | 2.36 | 0.00785 | 0.048679 |
GO:0044057 | regulation of system process | 3.61% (3/83) | 2.89 | 0.007924 | 0.048993 |
GO:0010038 | response to metal ion | 10.84% (9/83) | 1.37 | 0.008046 | 0.049454 |
GO:0097159 | organic cyclic compound binding | 37.35% (31/83) | 0.58 | 0.008036 | 0.049537 |